Search research articles
Contact Us
Filters
Showing results (1-10 of 31) with videos related to
Page
of 4
Sort By:
Biochimica Et Biophysica Acta. Reviews on Cancer
|
December 26, 2024
Nervous system contributions to small cell lung cancer: Lessons from diverse oncological studies
Shuangsi Liao, Kai Kang, Zhuoran Yao, et al.
Cancer Letters
|
May 21, 2023
Tackling the current dilemma of immunotherapy in extensive-stage small cell lung cancer: A promising strategy of combining with radiotherapy
Kai Kang, Yijun Wu, Zhuoran Yao, et al.
Cell Reports. Medicine
|
August 28, 2025
Addressing clinical needs in NSCLC immunotherapy: Mechanisms of resistance and promising combination strategies
Kai Kang, Shanghai Liu, Zhuoran Yao, et al.
Clinical Immunology (Orlando, Fla.)
|
March 6, 2020
Immune-related adverse events of checkpoint inhibitors: Insights into immunological dysregulation
Huaxia Yang, Zhuoran Yao, Xiaoxiang Zhou, et al.
Frontiers in Immunology
|
March 13, 2026
Stem-like T cells in cancer immunotherapy: biology, regulation and therapeutic targeting
Hui Wang, Zhuoran Yao, Ren Luo, et al.
Cancer Medicine
|
March 23, 2023
Efficacy and toxicity profile of first-line treatment for extensive-stage small cell lung cancer: A Bayesian network meta-analysis
Guo Lin, Zhuoran Yao, Kai Kang, et al.
Journal of Translational Medicine
|
April 17, 2025
Dynamic evolution and antitumor mechanisms of CXCR6<sup>+</sup>CD8<sup>+</sup> T cells in small cell lung cancer treated with low-dose radiotherapy and immunotherapy
Guo Lin, Zhuoran Yao, Kai Kang, et al.
BMC Medicine
|
April 21, 2020
Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis
Xiaoxiang Zhou, Zhuoran Yao, Huaxia Yang, et al.
Frontiers in Immunology
|
November 28, 2022
Real-world landscape transition of death causes in the immunotherapy era for metastatic non-small cell lung cancer
Yijun Wu, Zhuoran Yao, Jianhui Zhang, et al.
Frontiers in Oncology
|
June 20, 2022
Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
Yue Zheng, Laduona Wang, Limei Yin, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 31) with videos related to
Sort By:
Page
of 4
Biochimica Et Biophysica Acta. Reviews on Cancer
|
December 26, 2024
Nervous system contributions to small cell lung cancer: Lessons from diverse oncological studies
Shuangsi Liao, Kai Kang, Zhuoran Yao, et al.
Cancer Letters
|
May 21, 2023
Tackling the current dilemma of immunotherapy in extensive-stage small cell lung cancer: A promising strategy of combining with radiotherapy
Kai Kang, Yijun Wu, Zhuoran Yao, et al.
Cell Reports. Medicine
|
August 28, 2025
Addressing clinical needs in NSCLC immunotherapy: Mechanisms of resistance and promising combination strategies
Kai Kang, Shanghai Liu, Zhuoran Yao, et al.
Clinical Immunology (Orlando, Fla.)
|
March 6, 2020
Immune-related adverse events of checkpoint inhibitors: Insights into immunological dysregulation
Huaxia Yang, Zhuoran Yao, Xiaoxiang Zhou, et al.
Frontiers in Immunology
|
March 13, 2026
Stem-like T cells in cancer immunotherapy: biology, regulation and therapeutic targeting
Hui Wang, Zhuoran Yao, Ren Luo, et al.
Cancer Medicine
|
March 23, 2023
Efficacy and toxicity profile of first-line treatment for extensive-stage small cell lung cancer: A Bayesian network meta-analysis
Guo Lin, Zhuoran Yao, Kai Kang, et al.
Journal of Translational Medicine
|
April 17, 2025
Dynamic evolution and antitumor mechanisms of CXCR6<sup>+</sup>CD8<sup>+</sup> T cells in small cell lung cancer treated with low-dose radiotherapy and immunotherapy
Guo Lin, Zhuoran Yao, Kai Kang, et al.
BMC Medicine
|
April 21, 2020
Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis
Xiaoxiang Zhou, Zhuoran Yao, Huaxia Yang, et al.
Frontiers in Immunology
|
November 28, 2022
Real-world landscape transition of death causes in the immunotherapy era for metastatic non-small cell lung cancer
Yijun Wu, Zhuoran Yao, Jianhui Zhang, et al.
Frontiers in Oncology
|
June 20, 2022
Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies
Yue Zheng, Laduona Wang, Limei Yin, et al.
Page
of 4